8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K



              CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported): February 16, 2005


                         Commission File Number 1-09623


                                IVAX CORPORATION



           Florida                                            16-1003559
- -------------------------------                          ---------------------
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                           Identification No.)




               4400 Biscayne Boulevard, Miami, Florida            33137
               ----------------------------------------         ----------
               (Address of principal executive offices)         (Zip Code)


                                 (305) 575-6000
                                 --------------
              (Registrant's telephone number, including area code)


Check the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (See General Instruction A.2. below):


[_]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 13e-4(c))






Item 5.02 Departure of Directors or principal Officers; Election of Directors;
          Appointment of Principal Officers.

On February 16, 2005 Richard M. Krasno Ph.D. was nominated and appointed to the
board of directors of IVAX Corporation. On February 16, 2005, Dr. Krasno's
appointment was announced by IVAX in a press release which is attached hereto as
Exhibit 99.1 and incorporated by reference herein.








                                   Signatures


         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                         IVAX Corporation



         Date:  February 16, 2005        By: /s/Thomas E. Beier
                                             --------------------------------
                                             Thomas E. Beier
                                             Senior Vice President-Finance
                                             Chief Financial Officer

EX-99.1

                                                                    Exhibit 99.1


           IVAX Names Richard M. Krasno, Ph.D. to Board of Directors


    MIAMI--(BUSINESS WIRE)--Feb. 16, 2005--IVAX Corporation (AMEX:IVX)
(LSE:IVX.L) (WSE:IVX.WA) announced the nomination and appointment of
Richard M. Krasno, Ph.D. to its Board of Directors.
    Dr. Krasno currently serves as the Executive Director of the
William R. Kenan, Jr. Charitable Trust and as President of the four
affiliated William R. Kenan, Jr. Funds in Chapel Hill, North Carolina.
Prior to joining the Trust, Dr. Krasno was president of the Monterey
Institute of International Studies in Monterey, California. From
1981-1998 he served as President and Chief Executive Officer of the
Institute of International Education in New York. He also served as
Deputy Assistant Secretary of Education in Washington, D.C. Dr. Krasno
holds a Ph.D. from Stanford University and honorary doctorates from
Sacred Heart University and the College of St. Rose. He has held
academic appointments at the University of Chicago, Stanford
University, the University of Massachusetts and the University of
Santiago de Compostela, Spain, where he was a Senior Fulbright
Professor. Dr. Krasno serves on a number of corporate and non-profit
boards and is a past chairman of the regional Rhodes Scholarship
selection committee in North Carolina. He is also a trustee of the
Eisenhower Fellowship Program and a director of UNC Health Care which
is the governing body for the four University of North Carolina
Hospitals and the School of Medicine.
    Phillip Frost, M.D., chairman and chief executive officer of IVAX,
said, "Dr. Krasno brings great business and administrative experience
to IVAX' Board. We are fortunate to have the benefit of his knowledge
in diverse fields of interest at IVAX."
    IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.
    Copies of this and other news releases may be obtained free of
charge from IVAX' website at http://www.ivax.com.



    CONTACT: IVAX Corporation, Miami
             David Malina, 305-575-6043